Delivery Order SPE2DB20D2104-SPE2DB22FR99Z
- Not listed
- This federal contract award, valued at $2,284.50, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of SHINGRIX VIAL KITS, a medical product, with a completion date of December 30, 2024. The contract is a Delivery Order under an Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with the DLA Troop Support Medical. This IDC...
- This federal contract award, valued at $15,984.80, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 between Amerisourcebergen and the DLA Troop Support Medical, which runs through November 2026. The contract is for the delivery of SHINGRIX VIAL KITS, a pharmaceutical product, with a...
- This federal contract award, valued at $6,272.44, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract covers the delivery of SHINGRIX VIAL KITS, a medical product, with a completion date of December 27, 2024. This award is part of a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, valued at $999,999,999 and running through November...
- This federal contract award, valued at $5,345.05, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of SHINGRIX vial kits. The contract is a Delivery Order under an Indefinite Delivery Contract (IDC) held by Amerisourcebergen's parent company, Cencora, Inc., with the DLA Troop Support Medical. This IDC, valued at up to $999,999,999.00, serves as the primary vehicle for Amerisourcebergen to provide a comprehensive...
- This federal contract award, valued at $2,572.48, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical sourcing and distribution services company. The award is for the delivery of SHINGRIX Vial Kits, a pharmaceutical product, to support military treatment programs and facilities. The contract is a firm fixed price delivery order with a period of performance through...
- This federal contract award, valued at $5,540.24, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of SHINGRIX VIAL KITS, which are likely medical supplies or pharmaceutical products. The contract is a Delivery Order under an Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA, valued at $999,999,999 and running through November 2026....
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,693.38, is for the delivery of SHINGRIX VIAL KITS and is a firm fixed-price Delivery Order. The contract does not have a set-aside designation, indicating open competition. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
- This federal contract award was issued by the Defense Logistics Agency (DLA), a defense agency, to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $4,556.72 Delivery Order contract is for the delivery of SHINGRIX VIAL KITS, a pharmaceutical product, with a performance period ending on May 14, 2025. The contract is a Firm Fixed Price arrangement and does not have a set-aside designation, indicating open competition. AmerisourceBergen Drug...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,278.36, is a Delivery Order contract with a Firm Fixed Price pricing type. It is for the procurement of SHINGRIX VIAL KITS, a medical product, with a period of performance through March 21, 2025. The contract is not designated with a set-aside requirement, indicating open competition....
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the provision of SHINGRIX VIAL KITS. The contract is a Delivery Order valued at $2,763.84 with a firm fixed price and an ultimate completion date of December 20, 2024. The contract is not designated as a set-aside. This contract award is part of a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA Troop Support...
- SPE2DB20D2104Indefinite Delivery Contract
- SPE2DB20D2104-SPE2DB22FR99ZDelivery Order
This federal contract award, valued at $2,710.24, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of SHINGRIX VIAL KITS, a medical product, and represents a Delivery Order under the company's Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which has a potential value of up to $999,999,999.00 and runs through November 2026. The contract is a Firm Fixed Price arrangement and does not have a set-aside designation, indicating open competition. Amerisourcebergen, a subsidiary of the parent company Cencora, Inc., has a proven track record of supplying a wide range of pharmaceutical products and medical supplies to support the healthcare needs of the U.S. military and veterans' programs. This specific award is part of the company's broader role as a critical vendor for the DLA, delivering essential medical commodities to military treatment facilities and government healthcare institutions.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.7k | 3/7/22 |